About Eledon Pharmaceuticals, Inc. (ELDN)
Eledon Pharmaceuticals, Inc. is a publicly traded company listed on a major US stock exchange under the ticker symbol ELDN. All of Eledon Pharmaceuticals, Inc.'s regulatory filings are tracked under CIK number 0001404281 in the SEC EDGAR (Electronic Data Gathering, Analysis, and Retrieval) system — the official database of the U.S. Securities and Exchange Commission.
According to SEC regulations, all publicly traded companies in the United States are required to file periodic reports disclosing their financial condition, operating results, and material business events. This page aggregates Eledon Pharmaceuticals, Inc.'s most recent filings in one place.
Why Review ELDN SEC Filings?
SEC filings are the most authoritative and legally binding source of financial information for any publicly traded company. Unlike earnings calls, press releases, or third-party analyst reports, SEC filings are required by law to be accurate, complete, and not misleading — under penalty of securities fraud (Section 10(b) of the Securities Exchange Act of 1934).
For investors researching Eledon Pharmaceuticals, Inc. (ELDN), the key filing types include:
- 10-K Annual Reports — Comprehensive yearly financial overview with audited statements, risk factors, and management discussion & analysis (MD&A). Filed once per fiscal year.
- 10-Q Quarterly Reports — Unaudited quarterly financial data showing performance trends, filed three times per year during non-annual quarters.
- 8-K Current Reports — Real-time disclosures of material corporate events such as executive departures, mergers, acquisitions, or significant contract wins.
- Form 4 Insider Trading Disclosures — Transactions by Eledon Pharmaceuticals, Inc. officers, directors, and 10%+ shareholders, required within 2 business days of the trade.
Tip: Cross-reference ELDN's 10-K risk factors year-over-year to identify emerging threats or improving conditions. Learn more in our guide to reading SEC filings.
How MoneySense AI Helps You Analyze ELDN Filings
MoneySense AI is a personal finance platform that uses artificial intelligence to help you budget, save, and grow your money smarter. The SEC Filing Analysis tool is designed for retail and institutional investors who want to extract insights from lengthy SEC documents without reading hundreds of pages manually.
With MoneySense AI, you can:
- Instantly summarize any ELDN 10-K or 10-Q filing — turn 200+ page reports into actionable bullet points
- Detect sentiment shifts — identify whether management language has become more bullish, bearish, or neutral compared to prior filings
- Extract key financial metrics — automatically pull revenue, net income, EPS, operating margins, and year-over-year growth rates
- Identify red flags — surface accounting irregularities, unusual risk factor additions, related-party transactions, or concerning language patterns
- Compare filings — track changes between sequential 10-K or 10-Q filings to spot material shifts
Key Financial Terms in ELDN SEC Filings
Understanding the terminology used in Eledon Pharmaceuticals, Inc.'s SEC filings is essential for accurate analysis:
| Term | Definition | |------|-----------| | 10-K | Annual report filed with the SEC containing audited financial statements | | 10-Q | Quarterly report with unaudited interim financial data | | 8-K | Current report for material events occurring between periodic filings | | Form 4 | Insider trading disclosure by officers, directors, and major shareholders | | MD&A | Management Discussion & Analysis — narrative explanation of financial results | | CIK | Central Index Key — SEC's unique identifier for filing entities | | EDGAR | Electronic Data Gathering, Analysis, and Retrieval — SEC's filing database |
Learn more about these concepts in our financial terms glossary.
Explore More on MoneySense AI
- Latest 10-K Filings — Most recent annual reports across all companies
- Latest 8-K Filings — Real-time material event disclosures
- SEC Filing Analysis Tool — Upload and analyze any SEC filing with AI
- Financial Calculators — ROI, compound interest, DCF, and more
- Browse All Companies — SEC filings for 12,000+ US public companies
Disclaimer: This page provides SEC filing data sourced from the SEC EDGAR database for informational and educational purposes only. MoneySense AI does not provide investment advice, legal advice, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.